Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2018 | Determining the quality of life in long-term survivors of ovarian cancer

Speaking from the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany, Jalid Sehouli, MD, of the Charité University of Medicine Berlin, Berlin, Germany, discusses a study to helping determine the quality of life in women with long-term survival from ovarian cancer, and suggests a role for preoperative c-reactive protein in predicting survival among long-term survivors of ovarian cancer.